SCHEMBL7128853

SCHEMBL7128853

CC(=O)Nc1cccc(-c2csc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)n2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.62
MEN1 O00255 8/20 0.62
KMT2A Q03164 8/20 0.62
ALDH1A1 P00352 5/20 0.62
KDM4E B2RXH2 2/20 0.62
SMN1; SMN2 Q16637 7/20 0.59
HTT P42858 4/20 0.59
BAZ1A Q9NRL2 1/20 0.57
RAB9A P51151 5/20 0.57
LMNA P02545 2/20 0.56
CYP1A2 P05177 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
ABL1 P00519 2/20 0.54
NPC1 O15118 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
NFKB1 P19838 3/20 0.54
MAPK1 P28482 2/20 0.54
NFKB2 Q00653 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7123649 0.96 MEN1 (0.62) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7130345 0.90 MEN1 (0.73) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7120002 0.90 RAB9A (0.66) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7128172 0.89 MEN1 (0.58) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7129226 0.89 MEN1 (0.56) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7128794 0.87 MEN1 (0.69) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7125926 0.87 MEN1 (0.64) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7129830 0.86 PPARG (0.59) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7130746 0.86 RAB9A (0.69) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7127621 0.85 ABL1 (0.63) MAPTMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MAPT 4391/4885MEN1 4865/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.